Biomedical Engineering Reference
In-Depth Information
powder inhalers. Drug delivery to the lungs-21, The Aerosol Society, Edinburgh, UK, 21:374-
377.
http://ddl-conference.org.uk/index.php?q=previous_conferences
. Accessed 4 Aug 2012
41. Copley M, Smurthwaite M, Roberts DL, Mitchell JP (2005) Revised internal volumes to those
provided by Mitchell JP and Nagel MW in “Cascade impactors for the size characterization of
aerosols from medical inhalers: their uses and limitations”. J Aerosol Med 18(3):364-366
42. Pantelides PN, Bogard H, Russell-Graham D, Cooper AD, Pitcairn GR (2011) Investigation
into the use of the fast screening impactor as an abbreviated impactor measurement (AIM) tool
for dry powder inhalers. In: Dalby RN, Byron PR, Peart J, Suman JD, Young PM (eds)
Respiratory drug delivery-Europe 2011. Davis Healthcare, River Grove, IL, pp 391-395
43. Burnell PKP, Small T, Doig S, Johal B, Jenkins R, Gibson GJ (2001) Ex-vivo product perfor-
mance of Diskus™ and Turbuhaler™ inhalers using inhalation profiles from patients with
severe chronic obstructive pulmonary disease. Respir Med 95(5):324-330
44. Roberts DL, Chiruta M (2007) Transient impactor behavior during the testing of dry-powder
inhalers via compendial methods. Drug delivery to the lungs-18, The Aerosol Society,
Edinburgh, UK, 18:202-205
45. Pantelides PN, Bogard H, Russell-Graham D, Cooper AD, Pitcairn GR (2011) An evaluation
of a fast screening impactor (FSI) set-up for abbreviated impactor measurement: quality con-
trol (AIM-QC) of dry powder inhalers. UK Academy of Pharmaceutical Sciences (APSGB)
Inhalation 2011 meeting, University of Bath, UK, July (abstract)
46. Daniels GE, Hamilton M (2011) Assessment of early screening methodology using the
reduced next generation and fast screening impactor systems. In: Dalby RN, Byron PR, Peart
J, Suman JD, Young PM (eds) Respiratory drug delivery-Europe 2011. Davis Healthcare,
River Grove, IL, pp 327-330
47. Hamilton M, Daniels G (2011) Assessment of early screening methodology using the Next
Generation and Fast Screen Impactor systems. Drug delivery to the lungs-22, The Aerosol
Society, Edinburgh, UK, 22:355-358.
http://ddl-conference.org.uk/index.php?q=previous_
conferences
. Accessed 4 Aug 2012
48. Després-Gnis F, Williams G (2010) Comparison of next generation impactor and fast-screening
impactor for determining fine particle fraction of dry powder inhalers. Drug delivery to the
lungs-21, The Aerosol Society, Edinburgh, UK, 21:386-389.
http://ddl-conference.org.uk/
index.php?q=previous_conferences
. Accessed 4 Aug 2012
49. Rogueda P, Morrical B, Chew YD (2010) Comparison of NGI and the fast screening impactor
(FSI) for suitability for analytical drug development. Drug delivery to the lungs-21, The Aerosol
Society, Edinburgh, UK, 21:394-397.
http://ddl-conference.org.uk/index.php?q=previous_
conferences
. Accessed 4 Aug 2012
50. Sheng G, Zhang J, Simmons R, Watanabe W (2010) Fast screening impactor (FSI) as a pre-
screening tool for MDIs and nebulizers. In: Dalby RN, Byron PR, Peart J, Suman JD, Farr SJ,
Young PM (eds) Respiratory drug delivery-2010. Davis Healthcare, River Grove, IL,
pp 637-640
51. European Directorate for the Quality of Medicines and Healthcare (EDQM) (2012)
Preparations for nebulisation: characterisation, general chapter 2.9.44, Council of Europe,
Strasbourg, France
52. Tservistas M, Uhlig M, Mitchell J (2010) Assessment of abbreviated impactor measurement
(AIM) methods for nebulizer characterization. Drug delivery to the lungs-21, The Aerosol
Society, Edinburgh, UK, 21:378-381.
http://ddl-conference.org.uk/index.php?q=previous_
conferences
. Accessed 4 Aug 2012
53. Sheng G, Watanabe W (2010) Feasibility of fast screening impactor as a screening tool. Drug
delivery to the lungs-21, The Aerosol Society, Edinburgh, UK, 21:390-393.
http://ddl-
conference.org.uk/index.php?q=previous_conferences
. Accessed 4 Aug 2012
54. Dennis J, Berg E, Sandell D, Ali A, Lamb P, Tservistas M, Karlsson M, Mitchell J (2008)
Cooling the NGI: an approach to size a nebulised aerosol more accurately. Pharm Europa Sci
Notes 1:27-30
55. Fowdar N, Hammond M, Solomon D (2010) A comparison of the effect of continuous cooling
of an NGI on a solution and suspension based nebulized product. Drug delivery to the lungs-21,
Search WWH ::
Custom Search